Tandem Diabetes Shares Down 5% Following Disclosure Of Insider Sales Tue. Afternoon: 4 Execs/Directors Sold ~26K Shares, Of Which ~7K Shares Were Related To Option Exercise And 10b5-1 Trading Plan
Benzinga Newsdesk